The main goal of this study was to analyze the prognosis of dMMR stage III colon cancer and study the prognostic interplay between MMR status, tumor cell PD-L1 expression, and density of CD3+ and CD8+ lymphocytes. The gene discussed is CD274; the disease is neoplasm.